Lucy Shapiro, Director at Anacor Pharmaceuticals Inc (ANAC), sold 20,000 shares at $6.65 ($131K) on 2012-09-28, disclosed to the SEC on 2012-10-01.
Scheduled sale ($131k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.65 | 5,600 | $37K | 28.3% |
| 2 | $6.54 | 14,400 | $94K | 71.7% |
| Total | $6.57 avg | 20,000 | $131K | 100% |
| Filing → |
| ANAC | SELL | 2014-03-25 | $1.7M | — | Filing → |
| ANAC | SELL | 2013-04-19 | $200K | — | Filing → |
| ANAC | SELL | 2013-03-22 | $138K | — | Filing → |